JP2003532735A - 抗ウイルスピリミジンヌクレオシド類 - Google Patents

抗ウイルスピリミジンヌクレオシド類

Info

Publication number
JP2003532735A
JP2003532735A JP2001582349A JP2001582349A JP2003532735A JP 2003532735 A JP2003532735 A JP 2003532735A JP 2001582349 A JP2001582349 A JP 2001582349A JP 2001582349 A JP2001582349 A JP 2001582349A JP 2003532735 A JP2003532735 A JP 2003532735A
Authority
JP
Japan
Prior art keywords
alkyl
group
halogen
compound according
dideoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001582349A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003532735A5 (cg-RX-API-DMAC7.html
Inventor
マックギーガン,クリストファー
バルザリーニ,ヤン
デ・クラーク,エリック
Original Assignee
ユニバーシティ カレッジ カーディフ コンサルタンツ リミテッド
レガ・ファウンデーション
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ユニバーシティ カレッジ カーディフ コンサルタンツ リミテッド, レガ・ファウンデーション filed Critical ユニバーシティ カレッジ カーディフ コンサルタンツ リミテッド
Publication of JP2003532735A publication Critical patent/JP2003532735A/ja
Publication of JP2003532735A5 publication Critical patent/JP2003532735A5/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2001582349A 2000-05-09 2001-05-08 抗ウイルスピリミジンヌクレオシド類 Pending JP2003532735A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0011203.7 2000-05-09
GBGB0011203.7A GB0011203D0 (en) 2000-05-09 2000-05-09 Chemical compounds
PCT/GB2001/002004 WO2001085749A1 (en) 2000-05-09 2001-05-08 Anti-viral pyrimidine nucleoside analogues

Publications (2)

Publication Number Publication Date
JP2003532735A true JP2003532735A (ja) 2003-11-05
JP2003532735A5 JP2003532735A5 (cg-RX-API-DMAC7.html) 2008-04-03

Family

ID=9891276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001582349A Pending JP2003532735A (ja) 2000-05-09 2001-05-08 抗ウイルスピリミジンヌクレオシド類

Country Status (14)

Country Link
US (1) US7019135B2 (cg-RX-API-DMAC7.html)
EP (1) EP1280813B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003532735A (cg-RX-API-DMAC7.html)
AT (1) ATE254132T1 (cg-RX-API-DMAC7.html)
AU (1) AU780879B2 (cg-RX-API-DMAC7.html)
CA (1) CA2406633A1 (cg-RX-API-DMAC7.html)
DE (1) DE60101223T2 (cg-RX-API-DMAC7.html)
DK (1) DK1280813T3 (cg-RX-API-DMAC7.html)
ES (1) ES2210153T3 (cg-RX-API-DMAC7.html)
GB (1) GB0011203D0 (cg-RX-API-DMAC7.html)
NZ (1) NZ521877A (cg-RX-API-DMAC7.html)
PT (1) PT1280813E (cg-RX-API-DMAC7.html)
TR (1) TR200302313T4 (cg-RX-API-DMAC7.html)
WO (1) WO2001085749A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009536188A (ja) * 2006-05-09 2009-10-08 ユニバーシティ・カレッジ・カーディフ・コンサルタンツ・リミテッド 抗ウイルス性ピリミジンヌクレオシド誘導体

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7462605B2 (en) 1998-01-23 2008-12-09 Celmed Oncology (Usa), Inc. Phosphoramidate compounds and methods of use
ES2172303T3 (es) 1998-01-23 2002-09-16 Newbiotics Inc Agentes terapeuticos obtenidos por catalisis enzimatica.
US6683061B1 (en) 1999-07-22 2004-01-27 Newbiotics, Inc. Enzyme catalyzed therapeutic activation
IL147749A0 (en) 1999-07-22 2002-08-14 Newbiotics Inc Methods for treating therapy-resistant tumors
GB0009486D0 (en) 2000-04-17 2000-06-07 Univ Cardiff Chemical compounds
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
AU2003298658A1 (en) 2002-11-15 2004-06-15 Idenix (Cayman) Limited 2'-branched nucleosides and flaviviridae mutation
US7951789B2 (en) 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
GB201111779D0 (en) * 2011-07-08 2011-08-24 Univ Cardiff Chemical compounds
US9403863B2 (en) 2011-09-12 2016-08-02 Idenix Pharmaceuticals Llc Substituted carbonyloxymethylphosphoramidate compounds and pharmaceutical compositions for the treatment of viral infections
AR089650A1 (es) 2011-10-14 2014-09-10 Idenix Pharmaceuticals Inc Fosfatos 3,5-ciclicos sustituidos de compuestos de nucleotido de purina y composiciones farmaceuticas para el tratamiento de infecciones virales
EP2852604B1 (en) 2012-05-22 2017-04-12 Idenix Pharmaceuticals LLC 3',5'-cyclic phosphoramidate prodrugs for hcv infection
WO2013177195A1 (en) 2012-05-22 2013-11-28 Idenix Pharmaceuticals, Inc. 3',5'-cyclic phosphate prodrugs for hcv infection
MD20140134A2 (ro) 2012-05-22 2015-04-30 Idenix Pharmaceuticals, Inc. Compuşi ai D-aminoacizilor pentru tratamentul bolilor hepatice
PT2861611T (pt) 2012-05-25 2016-10-11 Janssen Sciences Ireland Uc Nucleósidos de espirooxetano de uracilo
WO2014052638A1 (en) 2012-09-27 2014-04-03 Idenix Pharmaceuticals, Inc. Esters and malonates of sate prodrugs
ES2674980T3 (es) 2012-10-08 2018-07-05 Idenix Pharmaceuticals Llc Análogos de 2'-cloro nucleósidos para infección por VHC
WO2014066239A1 (en) 2012-10-22 2014-05-01 Idenix Pharmaceuticals, Inc. 2',4'-bridged nucleosides for hcv infection
US9211300B2 (en) 2012-12-19 2015-12-15 Idenix Pharmaceuticals Llc 4′-fluoro nucleosides for the treatment of HCV
WO2014137930A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. Thiophosphate nucleosides for the treatment of hcv
WO2014137926A1 (en) 2013-03-04 2014-09-12 Idenix Pharmaceuticals, Inc. 3'-deoxy nucleosides for the treatment of hcv
EP2970357B1 (en) 2013-03-13 2025-01-01 Idenix Pharmaceuticals LLC Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv
EP2981542B1 (en) 2013-04-01 2021-09-15 Idenix Pharmaceuticals LLC 2',4'-fluoro nucleosides for the treatment of hcv
EP3004130B1 (en) 2013-06-05 2019-08-07 Idenix Pharmaceuticals LLC. 1',4'-thio nucleosides for the treatment of hcv
US20150037282A1 (en) 2013-08-01 2015-02-05 Idenix Pharmaceuticals, Inc. D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease
EP3131914B1 (en) 2014-04-16 2023-05-10 Idenix Pharmaceuticals LLC 3'-substituted methyl or alkynyl nucleosides for the treatment of hcv

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) * 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
WO1998049177A1 (en) * 1997-04-28 1998-11-05 University College Cardiff Consultants Limited Anti-viral pyrimidine nucleoside analogues
WO1999006422A2 (en) * 1997-07-31 1999-02-11 Nycomed Amersham Plc Base analogues

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62255499A (ja) * 1986-04-28 1987-11-07 Teijin Ltd 螢光性ヌクレオシド又はヌクレオチド
WO1998049177A1 (en) * 1997-04-28 1998-11-05 University College Cardiff Consultants Limited Anti-viral pyrimidine nucleoside analogues
WO1999006422A2 (en) * 1997-07-31 1999-02-11 Nycomed Amersham Plc Base analogues

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009536188A (ja) * 2006-05-09 2009-10-08 ユニバーシティ・カレッジ・カーディフ・コンサルタンツ・リミテッド 抗ウイルス性ピリミジンヌクレオシド誘導体

Also Published As

Publication number Publication date
WO2001085749A1 (en) 2001-11-15
DE60101223D1 (de) 2003-12-18
US7019135B2 (en) 2006-03-28
AU5494501A (en) 2001-11-20
DK1280813T3 (da) 2004-03-22
DE60101223T2 (de) 2004-09-02
AU780879B2 (en) 2005-04-21
TR200302313T4 (tr) 2004-01-21
US20030176370A1 (en) 2003-09-18
GB0011203D0 (en) 2000-06-28
ATE254132T1 (de) 2003-11-15
NZ521877A (en) 2004-11-26
ES2210153T3 (es) 2004-07-01
EP1280813B1 (en) 2003-11-12
PT1280813E (pt) 2004-03-31
CA2406633A1 (en) 2001-11-15
EP1280813A1 (en) 2003-02-05

Similar Documents

Publication Publication Date Title
EP1280813B1 (en) Anti-viral pyrimidine nucleoside analogues
JP4514242B2 (ja) 抗ウイルスピリミジンヌクレオシド類似体
EP1274713B1 (en) Anti-viral pyrimidine nucleoside analogues
US6800629B2 (en) Pyrazine derivatives or salts thereof, pharmaceutical composition containing the same, and production intermediates thereof
NZ535246A (en) 3'-prodrugs of 2'-deoxy-beta-L-nucleosides
PL209765B1 (pl) Pirazynowy analog nukleotydu i jego zastosowanie
JPWO2001060834A1 (ja) 新規なピラジン誘導体またはその塩、それらを含有する医薬組成物並びにそれらの製造中間体
JPH09504541A (ja) 5‐フルオロウラシル誘導体
CN113164506B (zh) 二核苷酸化合物及其前体药物
JP2006520359A (ja) ヌクレオチド脂質エステル誘導体
EP0788507B1 (en) L-pyranosyl nucleosides
CN114206894B (zh) 可用于递送胺、酰胺和酚的前药平台
JP2004043371A (ja) 新規なピラジン誘導体またはその塩並びにそれらを含有する抗ウイルス剤
WO2026101522A1 (en) 2'-fluoro-6'methylene carbocyclic nucleosides and nucleotides and methods of treating poxvirus infections with same
WO2003068796A1 (en) 4’-c-cyano-2’-deoxypurine nucleosides
MXPA99009965A (en) Anti-viral pyrimidine nucleoside analogues
JPWO2007119624A1 (ja) 抗ヘルペスウイルス活性を有するヌクレオシド誘導体

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080213

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080213

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110517

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110815

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110822

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20111115